Abstract:Key PointsMotor neuron diseases (MNDs) are an etiologically heterogeneous group of disorders that are characterized by muscle weakness and/or spastic paralysis, which results from the selective degeneration of lower motor neurons and/or upper motor neurons, respectively.The MNDs currently being investigated are: amyotrophic lateral sclerosis (ALS), hereditary spastic paraplegia (HSP), primary lateral sclerosis (PLS), spinal muscular atrophy (SMA), spinal bulbar muscular atrophy (SBMA) and lethal congenital contracture syndrome (LCCS).ALS is the most common adult-onset MND for which there is no therapeutic treatment currently available. The hallmark of this disease is the selective death of motor neurons in the brain and spinal cord, which leads to the paralysis of voluntary muscles.Family-based linkage studies have led to the identification of eight genes for ALS. The protein products of these mutated genes are superoxide dismutase 1 (SOD1), alsin, senataxin, vesicle-associated membrane protein-associated protein B (VAPB), angiogenin, dynactin, TAR DNA-binding protein 43 (TDP43) and FUS.Mutations in the SOD1 gene are the most common genetic cause of familial ALS and account for 15–20% of autosomal dominant familial ALS cases (1–2% of all ALS cases).HSPs are the second most important group of MNDs in terms of the number of mutations identified and the resulting insights into the pathogenesis of MND. The 45 spastic paraplegia loci and 20 causative genes reported so far suggest various pathogenic mechanisms, including axonal transport, membrane trafficking and mitochondrial dysfunction.RNA-processing defects are observed in several MNDs, and in ALS the TARDBP and FUS genes have provided direct links to defects in RNA processing as a broad pathway that contributes to motor neuron degeneration (however, this is not the case for HSP).

Update on Inherited Pediatric Motor Neuron Diseases: Clinical Features and Outcome

Inherited Paediatric Motor Neuron Disorders: Beyond Spinal Muscular Atrophy

[Progress of Clinical and Genetic Research on Distal Hereditary Motor Neuropathy].

Genetic Identification of Pathogenic Variations of the DMD Gene: a Retrospective Study from 10,481 Neonatal Patients Based on Next-Generation Sequencing Data

Genetic architecture of motor neuron diseases

Genetics of motor neuron disorders: new insights into pathogenic mechanisms

Molecular mechanisms and therapeutic strategies for neuromuscular diseases

Hereditary Neuromuscular Disorders in Reproductive Medicine

Genetic and Clinical Advances of Congenital Muscular Dystrophy.

New developments in the diagnosis and management of motor neuron disease

Monozygotic Twins with Infantile Neuroaxonal Dystrophy: A Case Report and Literature Review

Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 2: diseases of motor neuron and skeletal muscle

An evaluation of clinical presentation and genetic testing approaches for patients with neuromuscular disorders

Early onset inherited peripheral neuropathies: the experience of a specialized referral center for genetic diagnosis achievement.

The genetics of motor neuron diseases

The role of autophagy-lysosomal pathway in motor neuron diseases

Myotonic dystrophies: an update on clinical features, molecular mechanisms, management, and gene therapy

Genetic testing for monogenic forms of motor neuron disease/amyotrophic lateral sclerosis in unaffected family members

New developments in Charcot-Marie-Tooth neuropathy and related diseases

The distal hereditary motor neuropathies

Overarching pathomechanisms in inherited peripheral neuropathies, spastic paraplegias, and cerebellar ataxias